FDA Approves First Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer
Today, the U.S. Food and Drug Administration approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system
First Therapy For Treatment Of Low-Grade Upper Tra | 16/04/2020 | By Darshana | 322
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy